Guest guest Posted August 31, 2005 Report Share Posted August 31, 2005 U N I T E D N A T I O N S Office for the Coordination of Humanitarian Affairs Integrated Regional Information Network (IRIN) - 1995-2005 ten years serving the humanitarian community [These reports do not necessarily reflect the views of the United Nations] CONTENT: 1 - GHANA: Government ploughs ahead with plans to produce AIDS drugs locally 1 - GHANA: Government ploughs ahead with plans to produce AIDS drugs locally ACCRA, 31 August (PLUSNEWS) - A new plant has begun production of antiretroviral (ARV) drugs as part of government plans to expand distribution of the life prolonging treatment for its HIV-positive citizens. Pharmaceutical company Dan - a joint venture between Danpong Pharmaceuticals of Ghana and Pharmaceuticals of China - has begun production of the generic versions of the ARVs from a new plant outside the capital Accra. Generic drugs are not restricted by patent laws but are identical in content and substantially cheaper than the brand-name drug, according to the World Health Organisation (WHO). Under Ghanaian law, only the government will be able to buy the generic drugs, which have met standards for distribution set by the state Food and Drugs Board (FDB). " We are collecting our letter of approval (from the FDB) to officially deal in these drugs in Ghana today, " Yaw Adu Gyamfi, Chief Executive officer of Dan told IRIN on Tuesday. The government is currently spending about US $6 million of state funds to provide ARVs to 2,600 patients, according to Gyamfi. But once the government starts buying the Dan drugs, the bill for the same treatments for the same number of people will drop by 45 percent to about US $3.37 million, Gyamfi said. However, most ARV treatments distributed in Ghana are paid for with money donated by the Global Fund to Fight AIDS, Tuberculosis (TB) and Malaria which insists on production quality tests by the WHO before setting up a purchase order. The Global Fund has approved over US $47 million of funds for health projects in Ghana. Over US $14 million of that is to be directed to a programme to accelerate access to prevention, care, support and treatment of all persons affected by HIV/AIDS, TB and malaria with a special HIV/AIDS element. Edith n of the WHO in Ghana told IRIN that the Fund's assessment process had begun, but could take a long time before a conclusion is reached. " It takes quite some time as it depends on the manufacturer's production quality which can vary from one manufacturer to another, " n said. The first assessments of the Dan plant will begin in September, said n, but she could give no indication when or if Global Fund money would be used to purchase the drugs. [ENDS] We have sent this message from a no-reply address to avoid bounced messages into our general email folder. Please do not hesitate to contact us at Mail@... with any comments or questions you may have [This Item is Delivered to the English Service of the UN's IRIN humanitarian information unit, but may not necessarily reflect the views of the United Nations. For further information, free subscriptions, or to change your keywords, contact e-mail: Irin@... or Web: http://www.irinnews.org . If you re-print, copy, archive or re-post this item, please retain this credit and disclaimer. Reposting by commercial sites requires written IRIN permission.] Copyright © UN Office for the Coordination of Humanitarian Affairs 2005 IRIN Contacts: PLUSNEWS Tel: +27 11 895-1900 Fax: +27 11 784-6759 Email: Mail@... To make changes to or cancel your subscription visit: http://www.irinnews.org/subscriptions Subscriber: AIDS treatments Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.